← FDA DRUG APPROVALS

FDA ANDA · ANDA204352

AMMONIA N 13

ammonia n-13

Sponsor: BIOMEDCL RES FDN

APPLICATION
ANDA204352
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-01
LATEST ACTION
2015-05-01
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

AMMONIA N 13Prescription
AMMONIA N-13 48.75mCi-487.5mCi/13ML (3.75-37.5mCi/ML) · INJECTABLE · INTRAVENOUS

Approval history

2015-05-01UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →